CEBPZOS

gene
On this page

Summary

CEBPZOS (CEBPZ opposite strand, HGNC:49288) is a protein-coding gene on chromosome 2p22.2, encoding Protein CEBPZOS (A8MTT3).

Located in mitochondrion.

Source: NCBI Gene 100505876 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_001322374

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:49288
Approved symbolCEBPZOS
NameCEBPZ opposite strand
Location2p22.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000218739
Ensembl biotypeprotein_coding
Entrez100505876

Gene structure

Transcript identifiers

Ensembl transcripts: 44 — 42 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000392061, ENST00000397064, ENST00000397226, ENST00000402297, ENST00000406711, ENST00000438935, ENST00000470216, ENST00000898764, ENST00000898765, ENST00000898766, ENST00000898767, ENST00000898768, ENST00000898769, ENST00000898770, ENST00000898771, ENST00000898772, ENST00000898773, ENST00000898774, ENST00000898775, ENST00000898776, ENST00000898777, ENST00000898778, ENST00000898779, ENST00000898780, ENST00000938662, ENST00000938663, ENST00000938664, ENST00000938665, ENST00000938666, ENST00000938667, ENST00000938668, ENST00000938669, ENST00000938670, ENST00000938671, ENST00000938672, ENST00000938673, ENST00000938674, ENST00000938675, ENST00000938676, ENST00000938677, ENST00000938678, ENST00000938679, ENST00000938680, ENST00000963820

RefSeq mRNA: 4 — MANE Select: NM_001322374 NM_001322373, NM_001322374, NM_001322375, NM_001322376

CCDS: CCDS82435

Canonical transcript exons

ENST00000402297 — 5 exons

ExonStartEnd
ENSE000015477833720164237201726
ENSE000015519553720104837201092
ENSE000015531793720186337204743
ENSE000036622603719970437199819
ENSE000038439423719649637196520

Expression profiles

Bgee: expression breadth ubiquitous, 242 present calls, max score 94.25.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.1134 / max 156.1556, expressed in 1794 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1975322.11341794

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
hindlimb stylopod muscleUBERON:000425294.25gold quality
right adrenal glandUBERON:000123393.29gold quality
left adrenal gland cortexUBERON:003582593.28gold quality
left adrenal glandUBERON:000123493.27gold quality
right adrenal gland cortexUBERON:003582793.16gold quality
oviduct epitheliumUBERON:000480492.78gold quality
islet of LangerhansUBERON:000000692.60gold quality
muscle of legUBERON:000138392.58gold quality
gastrocnemiusUBERON:000138892.55gold quality
buccal mucosa cellCL:000233692.33gold quality
left ovaryUBERON:000211992.24gold quality
calcaneal tendonUBERON:000370192.22gold quality
rectumUBERON:000105292.14gold quality
adrenal glandUBERON:000236991.98gold quality
adrenal tissueUBERON:001830391.98gold quality
smooth muscle tissueUBERON:000113591.91gold quality
right ovaryUBERON:000211891.53gold quality
adrenal cortexUBERON:000123591.49gold quality
Brodmann (1909) area 9UBERON:001354091.41gold quality
adenohypophysisUBERON:000219691.29gold quality
muscle layer of sigmoid colonUBERON:003580591.25gold quality
anterior cingulate cortexUBERON:000983591.21gold quality
right uterine tubeUBERON:000130291.16gold quality
body of uterusUBERON:000985391.16gold quality
lower esophagus muscularis layerUBERON:003583390.71gold quality
heart left ventricleUBERON:000208490.70gold quality
lower esophagusUBERON:001347390.70gold quality
esophagogastric junction muscularis propriaUBERON:003584190.65gold quality
left lobe of thyroid glandUBERON:000112090.61gold quality
prefrontal cortexUBERON:000045190.57gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-135yes1834.74
E-ANND-3yes6.79

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

117 targeting CEBPZOS, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3646100.0073.565283
HSA-MIR-432-3P100.0067.86705
HSA-MIR-4713-3P100.0065.92505
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-548P99.9872.253784
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-477599.9875.006394
HSA-MIR-548N99.9871.944170
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-365899.9673.874379
HSA-MIR-590-3P99.9674.346478
HSA-MIR-493-5P99.9672.472382
HSA-MIR-101-3P99.9475.032230
HSA-MIR-6744-5P99.9366.82748
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-129799.9173.413162
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-10395-5P99.8667.35676
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-576-5P99.8470.462582
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-139-5P99.8069.501399

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCebpzosENSMUSG00000062691
rattus_norvegicusCebpzosENSRNOG00000064368

Protein

Protein identifiers

Protein CEBPZOSA8MTT3 (reviewed: A8MTT3)

Alternative names: CEBPZ antisense RNA 1, CEBPZ opposite strand

All UniProt accessions (1): A8MTT3

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Mitochondrion membrane.

RefSeq proteins (4): NP_001309302, NP_001309303, NP_001309304, NP_001309305 (=MANE)

Domains & families (InterPro)

IDNameType
IPR037764CEBPZOSFamily

UniProt features (2 total): chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A8MTT3-F191.700.86

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 82 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP, GOCC_MITOCHONDRIAL_ENVELOPE, GOCC_ORGANELLE_ENVELOPE, chr2p22, LHX9_TARGET_GENES, NKX2_2_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR548P, MIR10527_5P, MIR4728_5P, MIR551B_5P

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial membrane (GO:0031966), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm1
intracellular membrane-bounded organelle1
mitochondrion1
mitochondrial envelope1
organelle membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

176 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CEBPZOSRUSF1Q96GQ5608
CEBPZOSATOSBQ7L5A3586
CEBPZOSMTRES1Q9P0P8522
CEBPZOSCCDC127Q96BQ5479
CEBPZOSEXOGQ9Y2C4461
CEBPZOSSAMD4BQ5PRF9453
CEBPZOSCOA7Q96BR5446
CEBPZOSFXYD4P59646422
CEBPZOSTMT1AQ9H8H3410
CEBPZOSPOLG2Q9UHN1394
CEBPZOSABRAXAS2Q15018377
CEBPZOSAPOOQ9BUR5370
CEBPZOSFOXN2P32314357
CEBPZOSRAB20Q9NX57353
CEBPZOSUQCC4Q4G0I0352

IntAct

8 interactions, top by confidence:

ABTypeScore
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
CEBPZOSH1-4psi-mi:“MI:0915”(physical association)0.400
repCEBPZOSpsi-mi:“MI:0914”(association)0.350
NDRG2CEBPZOSpsi-mi:“MI:0914”(association)0.350
PBXIP1CEBPZOSpsi-mi:“MI:0914”(association)0.350
SLC39A8CEBPZOSpsi-mi:“MI:0914”(association)0.350

ESM2 similar proteins: A1L2P2, A1XQT2, A5PJ82, A8MTT3, D2H617, D4ACP2, E2R5I0, F6USH3, G1QDE8, G1S9B8, O95139, P04038, P09669, P0CB93, P0CB94, P11951, P80977, Q02367, Q0MQ88, Q0MQ89, Q0MQ90, Q0MQE0, Q0MQE1, Q0Q4Z0, Q28EM2, Q28GF4, Q29259, Q3UIU2, Q4I8P5, Q5BKW8, Q5RK28, Q68EV8, Q78RX3, Q7YRJ8, Q7YRJ9, Q7YRK0, Q7YRK1, Q7YRK2, Q7YRK3, Q7YRK7

Diamond homologs: A8MTT3, Q8BTE5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1941 predictions. Top by Δscore:

VariantEffectΔscore
2:37201640:A:AGacceptor_gain1.0000
2:37201641:G:GGacceptor_gain1.0000
2:37202780:TTA:Tdonor_loss1.0000
2:37202781:TAC:Tdonor_loss1.0000
2:37202782:A:ACdonor_gain1.0000
2:37202782:ACTT:Adonor_loss1.0000
2:37202782:ACTTG:Adonor_gain1.0000
2:37202783:C:CGdonor_gain1.0000
2:37202783:CTT:Cdonor_gain1.0000
2:37202783:CTTG:Cdonor_gain1.0000
2:37202783:CTTGC:Cdonor_gain1.0000
2:37202861:CCAAA:Cacceptor_gain1.0000
2:37202862:CAAA:Cacceptor_gain1.0000
2:37202862:CAAAC:Cacceptor_gain1.0000
2:37202863:AAA:Aacceptor_gain1.0000
2:37202863:AAAC:Aacceptor_loss1.0000
2:37202864:AA:Aacceptor_gain1.0000
2:37202864:AAC:Aacceptor_loss1.0000
2:37202866:C:CAacceptor_loss1.0000
2:37202866:C:CCacceptor_gain1.0000
2:37202867:T:Cacceptor_gain1.0000
2:37202868:T:TCacceptor_gain1.0000
2:37202869:T:Cacceptor_gain1.0000
2:37202869:T:TCacceptor_gain1.0000
2:37202943:GCCTT:Gdonor_loss1.0000
2:37202944:CCTTA:Cdonor_loss1.0000
2:37202945:CTTA:Cdonor_loss1.0000
2:37202946:TTACC:Tdonor_loss1.0000
2:37202947:TACC:Tdonor_loss1.0000
2:37202948:A:AGdonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000055694 (2:37204976 A>C), RS1000098043 (2:37213654 T>A,C), RS1000113618 (2:37199207 C>G), RS1000140487 (2:37197054 C>A), RS1000229262 (2:37199423 T>C), RS1000300464 (2:37194574 C>G), RS1000730535 (2:37194781 G>A), RS1000928946 (2:37200884 A>T), RS1001182216 (2:37216175 C>A,T), RS1001199992 (2:37205410 G>A), RS1001349534 (2:37209884 T>A,C), RS1001552730 (2:37198636 G>A), RS1001876418 (2:37205761 C>A,G), RS1001878456 (2:37199803 G>C), RS1001939760 (2:37204383 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cadmium Chloridedecreases expression, increases abundance2
dicrotophosdecreases expression1
beta-lapachoneincreases expression1
jinfukangaffects cotreatment, increases expression1
Cadmiumdecreases expression, increases abundance1
Cisplatinaffects cotreatment, increases expression1
Doxorubicindecreases expression1
Valproic Acidincreases expression1
Aflatoxin B1increases expression1
Okadaic Aciddecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.